Oncolytics Biotech Inc. (NASDAQ:ONCY) went up by 6.72% from its latest closing price compared to the recent 1-year high of $4.70. The company’s stock price has collected 23.13% of gains in the last five trading sessions. Press Release reported 2 hours ago that Oncolytics Biotech(R) Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors
Is It Worth Investing in Oncolytics Biotech Inc. (NASDAQ :ONCY) Right Now?
Plus, the 36-month beta value for ONCY is at 2.90. Opinions of the stock are interesting as 5 analysts out of 5 who provided ratings for Oncolytics Biotech Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $8.45. ONCY currently public float of 42.46M and currently shorts hold a 5.61% ratio of that float. Today, the average trading volume of ONCY was 1.86M shares.
ONCY’s Market Performance
ONCY stocks went up by 23.13% for the week, with a monthly jump of 21.32% and a quarterly performance of 64.18%, while its annual performance rate touched 25.48%. The volatility ratio for the week stands at 16.64% while the volatility levels for the past 30 days are set at 9.72% for Oncolytics Biotech Inc.. The simple moving average for the period of the last 20 days is 25.76% for ONCY stocks with a simple moving average of 58.11% for the last 200 days.
Analysts’ Opinion of ONCY
Many brokerage firms have already submitted their reports for ONCY stocks, with H.C. Wainwright repeating the rating for ONCY by listing it as a “Buy.” The predicted price for ONCY in the upcoming period, according to H.C. Wainwright is $15 based on the research report published on February 17th of the current year 2021.
ONCY Trading at 32.12% from the 50-Day Moving Average
After a stumble in the market that brought ONCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.07% of loss for the given period.
Volatility was left at 9.72%, however, over the last 30 days, the volatility rate increased by 16.64%, as shares surge +40.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.99% upper at present.
During the last 5 trading sessions, ONCY rose by +16.94%, which changed the moving average for the period of 200-days by +107.06% in comparison to the 20-day moving average, which settled at $2.85. In addition, Oncolytics Biotech Inc. saw 38.66% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ONCY
The total capital return value is set at -610.99, while invested capital returns managed to touch -1,059.27. Equity return is now at value -190.80, with -108.50 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.47.